Gene · 5603
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A virus-target host proteins recognition method based on integrated complexes data and seed extension. | BMC Bioinformatics | 2022 | 35764916 | PubTator, text mining | PubMed |
| Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression. | Cancer Metastasis Rev | 2022 | 35761157 | PubTator, text mining | PubMed |
Personalized Nutrition Using Microbial Metabolite Phenotype to Stratify Participants and Non-Invasive Host Exfoliomics Reveal the Effects of Flaxseed Lignan Supplementation in a Placebo-Controlled Crossover Trial. | Nutrients | 2022 | 35745107 | PubTator, text mining | PubMed |
| Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern. | Int J Mol Sci | 2022 | 35743273 | PubTator, text mining | PubMed |
| Functional regulations between genetic alteration-driven genes and drug target genes acting as prognostic biomarkers in breast cancer. | Sci Rep | 2022 | 35739271 | PubTator, text mining | PubMed |
| Time-resolved phosphoproteome and proteome analysis reveals kinase signaling on master transcription factors during myogenesis. | iScience | 2022 | 35721465 | PubTator, text mining | PubMed |
| PBRM1 Deficiency Sensitizes Renal Cancer Cells to DNMT Inhibitor 5-Fluoro-2'-Deoxycytidine. | Front Oncol | 2022 | 35719970 | PubTator, text mining | PubMed |
| Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature. | Hepatol Commun | 2022 | 35712812 | PubTator, text mining | PubMed |
| Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3β inhibitors for Alzheimer's disease. | J Enzyme Inhib Med Chem | 2022 | 35698879 | PubTator, text mining | PubMed |
Loss of CHGA Protein as a Potential Biomarker for Colon Cancer Diagnosis: A Study on Biomarker Discovery by Machine Learning and Confirmation by Immunohistochemistry in Colorectal Cancer Tissue Microarrays. | Cancers (Basel) | 2022 | 35681650 | PubTator, text mining | PubMed |
| PROTACs: great opportunities for academia and industry (an update from 2020 to 2021). | Signal Transduct Target Ther | 2022 | 35680848 | PubTator, text mining | PubMed |
| Comparative Analysis of Gene Expression Patterns for Oral Epithelial Cell Functions in Periodontitis. | Front Oral Health | 2022 | 35677025 | PubTator, text mining | PubMed |
| Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer. | BMC Cancer | 2022 | 35672711 | PubTator, text mining | PubMed |
| PROTACs: past, present and future. | Chem Soc Rev | 2022 | 35671157 | PubTator, text mining | PubMed |
| Gene Expression Profile Analysis of Human Epidermal Keratinocytes Expressing Human Papillomavirus Type 8 E7. | Pathol Oncol Res | 2022 | 35665406 | PubTator, text mining | PubMed |
| The Emerging Role of Non-Coding RNAs in Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells. | Front Cell Dev Biol | 2022 | 35652090 | PubTator, text mining | PubMed |
| An Aging and Senescence-Related Gene Signature for Prognosis Prediction in Clear Cell Renal Cell Carcinoma. | Front Genet | 2022 | 35646056 | PubTator, text mining | PubMed |
| Gamma synuclein promotes cancer metastasis through the MKK3/6-p38MAPK cascade. | Int J Biol Sci | 2022 | 35637967 | PubTator, text mining | PubMed |
| Nanchangmycin regulates FYN, PTK2, and MAPK1/3 to control the fibrotic activity of human hepatic stellate cells. | Elife | 2022 | 35617485 | PubTator, text mining | PubMed |
| Extracellular vesicle biomarkers for pancreatic cancer diagnosis: a systematic review and meta-analysis. | BMC Cancer | 2022 | 35606727 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5603/papers?page=19